HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $8,336,000 | +19.6% | 131,860 | +0.4% | 0.94% | +34.9% |
Q4 2021 | $6,967,000 | -22.8% | 131,357 | +2.8% | 0.70% | -26.6% |
Q3 2021 | $9,020,000 | +15.6% | 127,783 | +9.2% | 0.95% | +2.4% |
Q2 2021 | $7,800,000 | -42.1% | 117,047 | -3.6% | 0.93% | -42.0% |
Q1 2021 | $13,472,000 | -7.7% | 121,362 | -1.3% | 1.61% | -14.3% |
Q4 2020 | $14,600,000 | +28.2% | 122,950 | -5.8% | 1.87% | +10.8% |
Q3 2020 | $11,387,000 | -0.4% | 130,510 | +2.3% | 1.69% | +0.4% |
Q2 2020 | $11,428,000 | – | 127,600 | – | 1.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |